Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sgm-1019 (1 trial)
Fatty Liver (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Trials (1 total)
Trial APIs (1 total)